{"id":"W2600737274","doi":"10.1200/jco.2006.24.18_suppl.3544","title":"Efficacy and safety of bevacizumab in combination with irinotecan and infusional 5-FU as first-line treatment for patients with metastatic colorectal cancer","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bevacizumab; Irinotecan; FOLFIRI; Regimen; Colorectal cancer; Internal medicine; Oncology; Chemotherapy; Chemotherapy regimen; Surgery; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001176149,0.000465884,0.001727785,0.0004844469,0.0002887072,0.0005835143,0.0003787906,0.0005884231,0.0009519269],"category_scores_gemma":[0.002159661,0.000251517,0.0006414347,0.0004060171,0.000281937,0.0004183504,0.0002205891,0.001276682,0.0002167705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009838556,"about_ca_system_score_gemma":0.0007591267,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004753065,"about_ca_topic_score_gemma":0.002286897,"domain_scores_codex":[0.999404,0.0003189892,0.00004299202,0.00007532191,0.0001052776,0.00005344588],"domain_scores_gemma":[0.9991412,0.0002029167,0.0002883824,0.00003959614,0.00004516591,0.0002827679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4516451,0.02423426,0.04416834,0.001379733,0.002357727,0.0005765631,0.0003471856,0.004116159,0.04642105,0.0001829471,0.002665777,0.4219052],"study_design_scores_gemma":[0.1485288,0.6844369,0.1424731,0.0002042205,0.002227027,0.0017123,0.00007017591,0.004477424,0.009324715,0.0001763906,0.006295215,0.00007375591],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.988386,0.009573846,0.0002192167,0.0002746435,0.00006335812,0.0003233359,0.0001148963,0.00003018889,0.001014447],"genre_scores_gemma":[0.9972534,0.001325275,0.0005583504,0.0001742626,0.0001072745,0.0001435617,0.0002101543,0.000005168082,0.0002226885],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001727785,"threshold_uncertainty_score":0.007138371,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04532469909777934,"score_gpt":0.4051658561591145,"score_spread":0.3598411570613351,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}